Found 20 matching trials
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio PHASE2 A Phase 2, Randomized, Placebo-controlled, Multicenter, Masked Study to Eva...
Show More Location
Associated Retina Consultants (01065)
Learn More & Join Trial
Pegcetacoplan (APL-2) in Neovascular AMD PHASE1 Safety Assessment of Pegcetacoplan in Patients with Neovascular AMD...
Location
Apellis Clinical Site
Learn More & Join Trial
Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled Syringe PHASE3 This is a phase 3, open-label study to evaluate the safety of pegcetacoplan...
Show More Location
California Retina Consultants
Learn More & Join Trial
Pilot Study to Assess Safety, Preliminary Efficacy and Pharmacokinetics of S.C. Pegcetacoplan (APL-2) in PNH Subjects. PHASE1 The objectives of the study are to assess the safety, tolerability, prelimi...
Show More Location
Prince of Wales Hospital
Learn More & Join Trial
Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy PHASE2 The primary objectives of the study are to assess the safety, tolerability ...
Show More Location
Retina Speciality Institute
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of APL-2 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) PHASE3 Evaluation of the Efficacy and Safety of APL-2 in Patients with Paroxysmal ...
Show More Location
University of Southern California
Learn More & Join Trial
A Phase I Study to Assess the Safety of Pegcetacoplan (APL-2) as an Add-On to Standard of Care in Subjects With PNH PHASE1 This study will be the initial exploration of pegcetacoplan in patients wit...
Show More Location
University of Southern California Norris Comprehensive Cancer Center
Learn More & Join Trial
Study to Evaluate the Safety of Intravitreal APL-2 in Patients Diagnosed With Geographic Atrophy PHASE1 Safety Assessment of APL-2 in Patients with Geographic Atrophy...
Location
California Retina Consultants
Learn More & Join Trial
MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS) PHASE2 This is a 24-month, Phase 2, multicenter, randomized, double-blind, placebo...
Show More Location
Cedars-Sinai Medical Center
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With PNH PHASE3 Evaluation of the Efficacy and Safety of Pegcetacoplan in Patients with Par...
Show More Location
Julian Coronel Medical Center
Learn More & Join Trial